Ocular gene therapy: current progress and future prospects

  • Colella P
  • Cotugno G
  • Auricchio A
  • 31


    Mendeley users who have this article in their library.
  • 57


    Citations of this article.


As gene therapy begins to produce its first clinical successes, interest in ocular gene transfer has grown owing to the favorable safety and efficacy characteristics of the eye as a target organ for drug delivery. Important advances also include the availability of viral and non-viral vectors that are able to efficiently transduce various ocular cell types, the use of intraocular delivery routes and the development of transcriptional regulatory elements that allow sustained levels of gene transfer in small and large animal models after a single administration. Here, we review recent progress in the field of ocular gene therapy. The first experiments in humans with severe inherited forms of blindness seem to confirm the good safety and efficacy profiles observed in animal models and suggest that gene transfer has the potential to become a valuable therapeutic strategy for otherwise untreatable blinding diseases. © 2008 Elsevier Ltd. All rights reserved.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Pasqualina Colella

  • Gabriella Cotugno

  • Alberto Auricchio

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free